biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by kuatoliveson Nov 11, 2016 2:47pm

150 Views

Post# 25451057

RE:RE:RE:RE:RE:RE:RE:RE:who is selling over 200 thousand shares at $1.35 today

I follow this stock only passively (no position), but the drop since the election anyway can be attributed to the larger names in the biotech space riding the biotech trump-bump and traders liquidating capital in the the CVE (and TSX) backwaters to ride that wave. Companies such as PHM and MSL have also been, unfortunately for them, rather flat or negative the last 3 days where the Concoridas and Valeants of the world are surging despite being steaming piles of dung.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide